Loading...
T cell receptor grafting allows virological control of hepatitis B virus infection
T cell therapy is a promising means to treat chronic hepatitis B virus (HBV) infection and HBV-associated hepatocellular carcinoma. T cells engineered to express an HBV-specific T cell receptor (TCR) may cure an HBV infection upon adoptive transfer. We investigated the therapeutic potential and safe...
Na minha lista:
| Udgivet i: | J Clin Invest |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society for Clinical Investigation
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6597229/ https://ncbi.nlm.nih.gov/pubmed/31039136 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI120228 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|